Matthew Jung

Matthew Jung has extensive experience in the pharmaceutical and clinical research industry. Matthew currently holds the position of Senior Director, Clinical Operations at Ovid Therapeutics since January 2022. Prior to this role, they served as the Director, Clinical Operations at Ovid Therapeutics from January 2020 to December 2021, and as the Associate Director, Clinical Operations from June 2018 to December 2019.

Before joining Ovid Therapeutics, Matthew worked at Ferring Pharmaceuticals as a Sr. Manager, Clinical Operations from June 2017 to May 2018.

Their earlier experience includes working at IVERIC bio, where they held the position of Manager, Clinical Development from November 2013 to June 2017. Prior to this role, they served as a Sr. Clinical Research Associate, Clinical Development from March 2009 to October 2013.

Matthew's career in the clinical research field began at the Cardiovascular Research Foundation as a Clinical Research Associate for Intravascular Ultrasound (IVUS) from July 2006 to December 2006. Matthew then transitioned to the role of Clinical Research Associate from January 2007 to February 2009.

Overall, Matthew Jung has held progressively advanced roles in clinical operations and development throughout their career, demonstrating their expertise and commitment to the field.

Matthew Jung attended Bucknell University, where they pursued a degree in Psychology. No specific information regarding the start year, end year, or field of study is provided.